Elevra Strengthens Growth Pipeline Through NAL Expansion and Strategic Funding
Elevra Lithium Limited (ASX: ELV) unveiled a major growth strategy centred on the accelerated expansion of its North American Lithium (NAL) operation and the advancement of the Moblan Lithium Project. The updated NAL scoping study outlined a staged brownfield expansion expected to lift annual spodumene concentrate production to 338 thousand tonnes while lowering unit operating costs and improving project economics. The expansion is projected to generate a post-tax NPV of approximately US$2.3 billion, supported by faster production growth and improved operational efficiencies.
To support these initiatives, Elevra secured a transformational financing package worth up to AU$441 million, including an institutional placement, convertible notes investment from Canada Growth Fund, and a share purchase plan. The company also repurchased and terminated a discounted Moblan offtake agreement, giving Elevra full control over its attributable production from the project. These developments strengthen Elevra’s strategic flexibility, enhance long-term cash flow potential, and reinforce its position as a leading North American hard-rock lithium producer.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Elevra Strengthens Growth Pipeline Through NAL Expansion and Strategic Funding
Elevra Lithium Limited (ASX: ELV) unveiled a major growth strategy centred on the accelerated expansion of its North American Lithium (NAL) operation and the advancement of the Moblan Lithium Project. The updated NAL scoping study outlined a staged brownfield expansion expected to lift annual spodumene concentrate production to 338 thousand tonnes while lowering unit operating costs and improving project economics. The expansion is projected to generate a post-tax NPV of approximately US$2.3 billion, supported by faster production growth and improved operational efficiencies.
To support these initiatives, Elevra secured a transformational financing package worth up to AU$441 million, including an institutional placement, convertible notes investment from Canada Growth Fund, and a share purchase plan. The company also repurchased and terminated a discounted Moblan offtake agreement, giving Elevra full control over its attributable production from the project. These developments strengthen Elevra’s strategic flexibility, enhance long-term cash flow potential, and reinforce its position as a leading North American hard-rock lithium producer.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au